InsiderTrades

Form 4 for ONC BeOne Medicines Ltd.

Accepted 2022-06-24 00:00:00 ET · period of report 2022-06-22 · accession 0001651308-22-000113 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-06-24 2022-06-22 ONC Wang Lai Gbl Head of R, D A - Grant $0.00 +125.3K 1.51M +9% $0
D 2022-06-24 2022-06-22 ONC Wang Lai Gbl Head of R, D A - Grant $0.00 +707.9K 707.9K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2022-06-22 A A 125,255 $0.00 1,509,989 D — — (F1) Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service.
2 Derivative Share Option (Right to Buy) 2022-06-22 A A 707,876 $0.00 707,876 D $11.98 · — to 2032-06-21 707,876 Ordinary Shares (F6) The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. (F7) These securities vest over a four-year period as follows: 25% on the first anniversary of June 22, 2022 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service.